Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Tsumura discloses agents for atherosclerosis

Oct. 18, 1996

First low-dose hydrochlorothiazide product approvable

Oct. 18, 1996

Antihypertensive combination cleared for marketing in the U.S.

Oct. 18, 1996

PRAISE trial demonstrates safety of calcium channel blocker in severe heart failure

Oct. 18, 1996

Significant progress in cardiovascular R&D at Yamanouchi

Oct. 11, 1996

BTG licenses drug for cardiac arrest

Oct. 11, 1996

New approval for carvedilol in congestive heart failure

Oct. 11, 1996

Clinical results with adenosine agonist

Oct. 11, 1996

Lynx licenses antisense compound for restenosis to Schwarz

Oct. 11, 1996

New antioxidant for atherosclerosis

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...